๐Ÿ“š Strengthening Our Expertise: Product-Specific Guidance


At Pharmexon, we believe in fostering a culture of continuous learning to stay ahead in a fast-paced regulatory landscape. Parvinder Punia recently led a focused training on Product-Specific Guidance.

The session was not just an opportunity to explore deeper legal frameworksโ€”it was a chance for our team to engage, exchange perspectives, and enhance their understanding of effectively navigating complex regulatory challenges.

Why internal training matter:

๐Ÿ” They align our collective knowledge with the latest developments.
๐Ÿ’ก They empower our team to tackle intricate projects with confidence.
๐Ÿค They cultivate collaboration and shared expertise across all levels.

Latest Posts
Regulatory Intelligence September – October 2024

The Pharmaceutical Industry is incredibly dynamic, with constant updates occurring all through various fields encompassing

๐Ÿšจ Important Update from the European Medicines Agency (EMA) ๐Ÿšจ

This fall a significant EMA update of guideline on Environmental Risk Assessment (ERA) for Medicinal

Pharmexon Company Breakfast

Only a couple of weeks ago, one of Pharmexonโ€™s favorite traditions occurredโ€” the Pharmexon Company

๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฒ๐˜…๐—ผ๐—ป ๐—ต๐—ฎ๐—ฑ ๐˜๐—ต๐—ฒ ๐—ฝ๐—น๐—ฒ๐—ฎ๐˜€๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐—ฎ๐˜๐˜๐—ฒ๐—ป๐—ฑ๐—ถ๐—ป๐—ด BioBridges Conference ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฐ ๐—ถ๐—ป ๐—ฃ๐—ฟ๐—ฎ๐—ด๐˜‚๐—ฒ!

From September 26th to 27th, the event brought together professionals in bioequivalence and pharmaceutical development,

Pharmexonโ€™s team would like to extend our heartfelt appreciation to all our friends, clients and partners.

CPHI Milan provided an incredible platform for us to meet with both our longstanding friends,